FDA Adverse Event Malfunction Summary report: N

PROVISC IBC

MDR report key: 2062235 · Received March 17, 2011

Report

Report Number
3002037047-2011-00010
Event Type
Malfunction
Date Received
March 17, 2011
Date of Event
February 15, 2011
Report Date
February 15, 2011
Manufacturer
ALCON - BELGIUM/ S.A.ALCON-COUVREUR N.V.
Product Code
LZP
PMA / PMN Number
P890047
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS RETURNED FOR ANALYSIS. INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFO BECOMES AVAILABLE. THE BATCH RECORD REVIEW SHOWED THAT ALL TESTING RESULTS ARE WITHIN SPECIFICATIONS. A RETENTION SAMPLE, OF THIS BATCH, WAS TESTED AND ALL RESULTS CONFORM TO THE SPECIFICATIONS FOR THE TESTED PARAMETERS. (B)(4).

Description of Event or Problem · 1

A SURGEON REPORTED THAT THE PRODUCT WAS LESS TRANSPARENT THAN USUAL. FOREIGN SUBSTANCES ("SNOW FLAKES" LIKE) WERE VISIBLE WHEN THE VISCOELASTIC WAS INJECTED IN THE ANTERIOR CHAMBER. SOON AFTER, THE VISCOELASTIC WAS REMOVED FROM THE ANTERIOR CHAMBER AND REPLACED WITH ANOTHER VISCOELASTIC WHICH WAS NOT DEFECTIVE. PT IMPACT IS UNK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROVISC IBC AID, SURGICAL, VISCOELASTIC LZP ALCON - BELGIUM/ S.A.ALCON-COUVREUR N.V. NA 10F22B

Patients

Seq Age Sex Outcome Treatment
1 BETABIOPTAL EYE DROPS